Nausicaa Ventures
Nausicaa Ventures, established in 2009, is a Belgium-based early-stage venture capital firm. It invests in early growth and early-stage companies primarily in Belgium, with a focus on projects within a 300 km radius of Brussels, extending to France, Luxembourg, Netherlands, Switzerland, and the United Kingdom. The firm targets investments in healthcare, medtech, ICT, manufacturing, clean technology, and high-tech industries, typically investing between €1 million to €4 million per company. Nausicaa Ventures prefers to invest alongside angel investors or family offices and has an average holding period of five years, aiming to exit after three to six years.
Top Stages
Past deals in Benelux
Ngdata
Series C in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Ngdata
Series B in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Ngdata
Series B in 2015
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Bone Therapeutics
Series D in 2013
Bone Therapeutics SA is a biotechnology company based in Gosselies, Belgium, that specializes in the development of innovative cell therapy products for orthopedics and bone diseases. Established in 2006, the company has created a robust product pipeline, including ALLOB, an allogeneic cell therapy currently in Phase II clinical trials aimed at treating delayed-union fractures and spinal fusion procedures. Bone Therapeutics also conducts preclinical research on next-generation products, such as combined cell-matrix therapies for large bone defects and maxillofacial applications. The company collaborates with various partners to develop personalized, tissue-engineered bone implants, leveraging its extensive expertise in bone and joint physiology, along with advanced production methods and minimally invasive treatment techniques.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.